Insider Selling: Humana Inc. (HUM) CEO Sells 12,000 Shares of Stock
Humana Inc. (NYSE:HUM) CEO Bruce D. Broussard sold 12,000 shares of the company’s stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the completion of the sale, the chief executive officer now directly owns 80,086 shares in the company, valued at $20,172,061.68. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Humana Inc. (HUM) traded up 0.10% during trading on Monday, reaching $250.25. 726,378 shares of the company’s stock traded hands. Humana Inc. has a one year low of $163.50 and a one year high of $255.27. The firm has a market cap of $36.17 billion, a price-to-earnings ratio of 20.59 and a beta of 0.91. The company has a 50 day moving average of $239.96 and a 200 day moving average of $223.57.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Zacks’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The firm had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter in the previous year, the company posted $2.30 earnings per share. Equities research analysts predict that Humana Inc. will post $11.55 EPS for the current year.
WARNING: “Insider Selling: Humana Inc. (HUM) CEO Sells 12,000 Shares of Stock” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/08/14/insider-selling-humana-inc-hum-ceo-sells-12000-shares-of-stock.html.
Several large investors have recently added to or reduced their stakes in HUM. Guardian Life Insurance Co. of America increased its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the period. Acrospire Investment Management LLC purchased a new stake in Humana during the second quarter worth approximately $120,000. Independent Portfolio Consultants Inc. increased its stake in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the period. Point72 Asia Hong Kong Ltd purchased a new stake in Humana during the first quarter worth approximately $128,000. Finally, Northwestern Mutual Wealth Management Co. increased its stake in Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares during the period. 99.13% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have recently weighed in on HUM shares. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $256.00 target price on the stock in a research report on Monday, May 8th. Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research report on Friday, June 9th. BidaskClub raised shares of Humana from a “hold” rating to a “buy” rating in a research report on Wednesday, June 21st. Citigroup Inc. started coverage on shares of Humana in a research report on Wednesday, June 28th. They issued a “buy” rating and a $275.00 target price on the stock. Finally, Bank of America Corporation upped their target price on shares of Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, July 14th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $243.65.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.